Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
580 | 13536 | 37.9 | 84% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
175 | 53899 | COLONOSCOPY//BARRETTS ESOPHAGUS//ESOPHAGEAL CANCER |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
160 | 4045 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
1661 | 2469 | PANITUMUMAB//CETUXIMAB//METASTATIC COLORECTAL CANCER |
4352 | 1725 | FAMILIAL ADENOMATOUS POLYPOSIS//APC GENE//MUTYH |
9570 | 1075 | SERRATED ADENOMA//SESSILE SERRATED ADENOMA//TRADITIONAL SERRATED ADENOMA |
11795 | 890 | DNA MULTIPLOIDY//DNA PLOIDY//DNA PLOIDY HETEROGENEITY |
11820 | 887 | ABERRANT CRYPT FOCI//BETA CATENIN ACCUMULATED CRYPTS//COLON CARCINOGENESIS |
16952 | 561 | HUMAN CYTOGENET TOXICOL GENET//C KI RAS ONCOGENE//JOAO BARROS BARRETO UNIV HOSP |
19353 | 445 | INTER SIMPLE SEQUENCE REPEAT PCR//BIOPHYS CYTOMETRY//HOSP UNIV SALAMANCA IBSAL |
20168 | 410 | FLAT ADENOMA//DEPRESSED ADENOMA//POLYPOID GROWTH |
21000 | 376 | COLONIC EFFLUENT//STOOL DNA//FECAL RNA |
21762 | 349 | MIN MOUSE//MIN MICE//FAP MODEL |
23041 | 304 | KIAA1199//MIR 188 5P//TRANSCRIPTOMIC PROFILES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MICROSATELLITE INSTABILITY | Author keyword | 1026 | 60% | 8% | 1114 |
2 | LYNCH SYNDROME | Author keyword | 751 | 75% | 4% | 541 |
3 | HNPCC | Author keyword | 576 | 75% | 3% | 420 |
4 | HEREDITARY NONPOLYPOSIS COLORECTAL CANCER | Author keyword | 264 | 74% | 1% | 194 |
5 | COLORECTAL CANCER | Author keyword | 262 | 12% | 16% | 2110 |
6 | PANITUMUMAB | Author keyword | 256 | 69% | 2% | 219 |
7 | SERRATED ADENOMA | Author keyword | 219 | 92% | 1% | 85 |
8 | MLH1 | Author keyword | 200 | 60% | 2% | 218 |
9 | HMLH1 | Author keyword | 195 | 66% | 1% | 179 |
10 | KRAS | Author keyword | 166 | 34% | 3% | 405 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MICROSATELLITE INSTABILITY | 1026 | 60% | 8% | 1114 | Search MICROSATELLITE+INSTABILITY | Search MICROSATELLITE+INSTABILITY |
2 | LYNCH SYNDROME | 751 | 75% | 4% | 541 | Search LYNCH+SYNDROME | Search LYNCH+SYNDROME |
3 | HNPCC | 576 | 75% | 3% | 420 | Search HNPCC | Search HNPCC |
4 | HEREDITARY NONPOLYPOSIS COLORECTAL CANCER | 264 | 74% | 1% | 194 | Search HEREDITARY+NONPOLYPOSIS+COLORECTAL+CANCER | Search HEREDITARY+NONPOLYPOSIS+COLORECTAL+CANCER |
5 | COLORECTAL CANCER | 262 | 12% | 16% | 2110 | Search COLORECTAL+CANCER | Search COLORECTAL+CANCER |
6 | PANITUMUMAB | 256 | 69% | 2% | 219 | Search PANITUMUMAB | Search PANITUMUMAB |
7 | SERRATED ADENOMA | 219 | 92% | 1% | 85 | Search SERRATED+ADENOMA | Search SERRATED+ADENOMA |
8 | MLH1 | 200 | 60% | 2% | 218 | Search MLH1 | Search MLH1 |
9 | HMLH1 | 195 | 66% | 1% | 179 | Search HMLH1 | Search HMLH1 |
10 | KRAS | 166 | 34% | 3% | 405 | Search KRAS | Search KRAS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MICROSATELLITE INSTABILITY | 1015 | 35% | 17% | 2348 |
2 | NONPOLYPOSIS COLORECTAL CANCER | 930 | 51% | 10% | 1307 |
3 | HNPCC | 820 | 80% | 4% | 513 |
4 | LYNCH SYNDROME | 636 | 61% | 5% | 679 |
5 | HMLH1 | 553 | 71% | 3% | 450 |
6 | MISMATCH REPAIR GENES | 397 | 72% | 2% | 308 |
7 | NONPOLYPOSIS COLON CANCER | 385 | 58% | 3% | 439 |
8 | HMSH2 | 352 | 77% | 2% | 239 |
9 | CETUXIMAB PLUS IRINOTECAN | 350 | 72% | 2% | 277 |
10 | PANITUMUMAB | 332 | 73% | 2% | 254 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FAMILIAL CANCER | 67 | 28% | 2% | 208 |
2 | CLINICAL COLORECTAL CANCER | 30 | 26% | 1% | 99 |
3 | HEREDITARY CANCER IN CLINICAL PRACTICE | 9 | 22% | 0% | 35 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials | 2015 | 12 | 15 | 100% |
Lessons from hereditary colorectal cancer | 1996 | 3252 | 87 | 62% |
Colorectal serrated pathway cancers and precursors | 2015 | 5 | 104 | 89% |
Genomic medicine - Hereditary colorectal cancer | 2003 | 865 | 77 | 68% |
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis | 2015 | 5 | 32 | 81% |
BRAF(V600E) Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis | 2014 | 20 | 36 | 94% |
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts | 2013 | 83 | 109 | 72% |
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | 2007 | 484 | 151 | 67% |
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis | 2014 | 20 | 36 | 86% |
Systematic review of microsatellite instability and colorectal cancer prognosis | 2005 | 630 | 79 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONJOINT GASTROENTEROL | 63 | 66% | 0.4% | 59 |
2 | DANISH HNPCC REGISTER | 35 | 86% | 0.1% | 18 |
3 | DIGEST ONCOL UNIT | 35 | 39% | 0.5% | 71 |
4 | NEW ZEALAND FAMILIAL GASTROINTESTINAL CANC REGIST | 31 | 92% | 0.1% | 12 |
5 | ONCOL SPERIMENTALE 1 | 27 | 92% | 0.1% | 11 |
6 | MOL POPULAT GENET | 26 | 29% | 0.6% | 77 |
7 | FAMILIAL GASTROINTESTINAL CANC REGISTRY | 25 | 66% | 0.2% | 23 |
8 | NETHERLANDS FDN DETECT HEREDITARY TUMOURS | 22 | 62% | 0.2% | 23 |
9 | GRP HUMAN GENET | 22 | 53% | 0.2% | 29 |
10 | BIOPHYS CYTOMETRY | 21 | 85% | 0.1% | 11 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014602 | CHROMATIN SUPRAORGANIZATION//ZNF703//NUCLEAR PHENOTYPES |
2 | 0.0000013483 | COLONOSCOPY//ENDOSCOPIC SUBMUCOSAL DISSECTION//COLORECTAL CANCER SCREENING |
3 | 0.0000012438 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
4 | 0.0000011943 | HETEROTOPIC PANCREAS//HETEROTOPIC GASTRIC MUCOSA//ECTOPIC PANCREAS |
5 | 0.0000011115 | BARRETTS ESOPHAGUS//BARRETTS OESOPHAGUS//ESOPHAGEAL ADENOCARCINOMA |
6 | 0.0000010552 | BRCA1//BRCA2//CHEK2 |
7 | 0.0000009371 | GENET CELL BIOL SECTCHUO KU//WNT//GENET CELL BIOL SECT |
8 | 0.0000008444 | ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//CYTOMETRY//IMAGE CYTOMETRY |
9 | 0.0000006916 | INTUSSUSCEPTION//PEUTZ JEGHERS SYNDROME//MR ENTEROGRAPHY |
10 | 0.0000006872 | HAND FOOT SYNDROME//RADIATION RECALL//EXTRAVASATION |